Ldt, Non-Molecular Antisera For Rare Rbc Antigens When There Is No Alternative Ivd
SCK is the FDA product code for Ldt, Non-Molecular Antisera For Rare Rbc Antigens When There Is No Alternative Ivd. FDA's definition for this code reads: "Non-molecular antisera laboratory developed tests (LDTs) for rare red blood cell (RBC) antigens when manufactured and performed by blood establishments, including transfusion services and immunohematology laboratories, and when there is no alternative in vitro diagnostic product (IVD) available to meet the patient's...". As of , FDA records hold no 510(k) clearances under this code and no recalls.
Classification record
- Product code
- SCK
- Device name
- Ldt, Non-Molecular Antisera For Rare Rbc Antigens When There Is No Alternative Ivd
- FDA definition
- Non-molecular antisera laboratory developed tests (LDTs) for rare red blood cell (RBC) antigens when manufactured and performed by blood establishments, including transfusion services and immunohematology laboratories, and when there is no alternative in vitro diagnostic product (IVD) available to meet the patient's need for a compatible blood transfusion within the scope described in Section V.B.3 of the preamble to the Final LDT Rule (89 FR 37286).
- Device class
- Not classified
- Review panel
- Unknown
- Submission type
- FDA code 7
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 0
- Ingested recalls
- 0
Companies listing this code with FDA
Companies whose registered establishments list this codeNo registered establishment in MDM’s records lists product code SCK.
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
